Viewray Inc (VRAY) Expected to Earn FY2017 Earnings of ($1.03) Per Share

Viewray Inc (NASDAQ:VRAY) – Analysts at Cantor Fitzgerald issued their FY2017 EPS estimates for Viewray in a research report issued to clients and investors on Sunday. Cantor Fitzgerald analyst C. Bijou anticipates that the company will post earnings of ($1.03) per share for the year. Cantor Fitzgerald currently has a “Buy” rating and a $13.00 price objective on the stock. Cantor Fitzgerald also issued estimates for Viewray’s FY2018 earnings at ($0.59) EPS.

Viewray (NASDAQ:VRAY) last released its earnings results on Monday, November 13th. The company reported ($0.19) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.12) by ($0.07). The business had revenue of $12.20 million for the quarter, compared to analyst estimates of $18.63 million. Viewray’s quarterly revenue was up 2950.0% on a year-over-year basis.

A number of other analysts also recently weighed in on VRAY. ValuEngine downgraded shares of Viewray from a “hold” rating to a “sell” rating in a research report on Friday, September 22nd. Mizuho reissued a “buy” rating and set a $12.00 target price on shares of Viewray in a research report on Tuesday, September 26th. Northland Securities reissued a “buy” rating and set a $10.00 target price on shares of Viewray in a research report on Friday, November 17th. Finally, BidaskClub downgraded shares of Viewray from a “buy” rating to a “hold” rating in a research report on Saturday, December 9th. One analyst has rated the stock with a sell rating, one has issued a hold rating and five have given a buy rating to the company. Viewray presently has an average rating of “Buy” and a consensus target price of $11.20.

Shares of Viewray (NASDAQ:VRAY) opened at $10.12 on Wednesday. The firm has a market cap of $649.77, a P/E ratio of -9.28 and a beta of 17.60. The company has a current ratio of 1.59, a quick ratio of 1.20 and a debt-to-equity ratio of -1.67. Viewray has a 52-week low of $3.01 and a 52-week high of $10.64.

Several hedge funds have recently made changes to their positions in VRAY. Schwab Charles Investment Management Inc. acquired a new stake in shares of Viewray during the 2nd quarter worth approximately $323,000. Rhumbline Advisers acquired a new stake in shares of Viewray during the 2nd quarter worth approximately $193,000. Bank of New York Mellon Corp grew its position in shares of Viewray by 146.4% during the 2nd quarter. Bank of New York Mellon Corp now owns 109,348 shares of the company’s stock worth $707,000 after buying an additional 64,976 shares during the period. Alliancebernstein L.P. acquired a new stake in shares of Viewray during the 2nd quarter worth approximately $248,000. Finally, White Pine Capital LLC acquired a new stake in shares of Viewray during the 2nd quarter worth approximately $173,000. 50.02% of the stock is owned by institutional investors.

COPYRIGHT VIOLATION WARNING: This article was originally published by Community Financial News and is the sole property of of Community Financial News. If you are accessing this article on another site, it was illegally stolen and republished in violation of US & international trademark & copyright legislation. The original version of this article can be viewed at https://www.com-unik.info/2018/01/12/viewray-inc-vray-expected-to-earn-fy2017-earnings-of-1-03-per-share.html.

Viewray Company Profile

ViewRay, Inc designs, manufactures and markets MRIdian, the magnetic resonance imaging (MRI)-guided radiation therapy system to image and treat cancer patients simultaneously. The Company offers radiation therapy technology combined with magnetic resonance imaging. MRIdian integrates MRI technology, radiation delivery and the Company’s software to locate, target and track the position and shape of soft-tissue tumors while radiation is delivered.

Receive News & Ratings for Viewray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viewray and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit